文献速递生殖医学

中性彗星试验检测双链精子DNA碎片预测IVF活产结局

Double-stranded sperm DNA fragmentation measured with neutral comet assay as a predictor of IVF outcomes: evidence from three European clinics in a multi-centred prospective study.
PubMed 文献 · Hum Reprod · 2026-01-01

该多中心前瞻性队列研究纳入三个欧洲IVF中心共302名男性,用中性彗星试验量化双链精子DNA碎片(dsSDF),以平均彗星评分(ACS)和损伤发生率(IOD)表示。结果显示dsSDF是IVF活产的独立预测因子,ACS每增加1分活产几率降低16%,IOD每增加1分降低5%;IOD≥6%时活产几率约为IOD<6%者的一半。

要点

  • 中性彗星试验测定的dsSDF可独立预测IVF活产,校正女方年龄、男方年龄和招募中心后仍显著。
  • ACS每增加1分,活产几率降低16%(OR=0.84,95%CI 0.72-0.97;P=0.026)。
  • IOD≥6%的夫妇活产几率约为IOD<6%者的一半(OR=0.51,95%CI 0.28-0.94;P=0.029)。

核心结论

  • 在中性彗星试验检测下,双链精子DNA碎片是IVF活产的强独立预测因子。
  • dsSDF与活产的不良关联在女方年龄较高时更强。

研究设计与样本

  • 另设126名已确认活产的健康精子供者作为对照。
  • dsSDF用中性彗星试验量化,以平均彗星评分(ACS)和损伤发生率(IOD)表示。
  • 主要结局为每启动周期的活产,采用多变量逻辑回归校正女方和男方年龄(敏感性分析中校正中心)。

主要发现

  • 全队列中30%的夫妇获得活产。
  • ACS每增加1分,活产几率降低16%(OR=0.84,95%CI 0.72-0.97;P=0.026)。
  • IOD每增加1分,活产几率降低5%(OR=0.95,95%CI 0.90-0.99;P=0.025)。
  • 女方年龄仍为活产的强负向预测因子(OR=0.86,95%CI 0.78-0.94;P<0.001)。
  • 以IOD≥6%为实用阈值,在女方年龄相近时,该组活产几率约为IOD<6%组的一半(OR=0.51,95%CI 0.28-0.94;P=0.029)。

关键数值与推荐

  • ACS每增加1分对应活产OR=0.84(95%CI 0.72-0.97;P=0.026)。
  • IOD每增加1分对应活产OR=0.95(95%CI 0.90-0.99;P=0.025)。
  • IOD≥6%阈值下活产OR=0.51(95%CI 0.28-0.94;P=0.029)。
  • 女方年龄活产OR=0.86(95%CI 0.78-0.94;P<0.001)。

临床怎么用

  • dsSDF可作为临床相关生物标志物,补充常规精液参数评估IVF活产概率。
  • IOD≥6%可识别活产几率约减半的夫妇,尤其在女方年龄较高时关联更强。

局限性

  • 研究仅纳入首次或唯一一次IVF周期的夫妇,未包括反复IVF失败者。
  • 可能存在中心层面混杂,混合效应模型或可改善。
  • 未收集或校正多个影响活产的周期层面协变量(如IVF vs ICSI、获卵数、胚胎移植策略、PGT-A使用、刺激方案),存在残余混杂可能。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

STUDY QUESTION: Can measurement of double-stranded sperm DNA fragmentation (dsSDF) via a neutral comet assay predict the probability of live birth following IVF? SUMMARY ANSWER: In a multicentre IVF cohort, dsSDF measured by a neutral comet assay was a strong, independent predictor of live birth. WHAT IS KNOWN ALREADY: While much of the focus has traditionally been on female factors, emerging research highlights sperm DNA fragmentation as a significant contributor to reproductive outcomes. Over the past decade, studies have shown that different types of sperm DNA damage can affect reproduction differently, with single-stranded breaks being closely linked to reduced spontaneous conception rates, while double-stranded breaks are linked to higher miscarriage rates. STUDY DESIGN, SIZE, DURATION: Prospective cohort study including a total of 302 males from three European IVF clinics, over a 3-year study period (March 2021-October 2024), with 126 healthy sperm donors with confirmed live birth serving as controls. PARTICIPANTS/MATERIALS, SETTING, METHODS: dsSDF was quantified with a neutral comet assay, expressed as Average Comet Score (ACS) and Incidence of Damage (IOD). The primary outcome was live birth per initiated cycle. Associations were evaluated using multivariable logistic regression, adjusting for female and male age (and centre in sensitivity analyses). MAIN RESULTS AND THE ROLE OF CHANCE: Across the cohort, 30% of couples achieved a live birth. Higher dsSDF was associated with reduced odds of live birth, and this association remained statistically significant after adjustment for female age, male age, and recruitment site. Both ACS and IOD were independently predictive of live birth in adjusted models. For ACS, each 1-point increase was associated with 16% lower odds of live birth (OR = 0.84, 95% CI 0.72-0.97; P = 0.026). For IOD, each 1-point increase corresponded to 5% lower odds of live birth (OR = 0.95, 95% CI 0.90-0.99; P = 0.025). As expected, female age remained a strong inverse predictor of live birth across models (OR = 0.86, 95% CI 0.78-0.94; P < 0.001). Using a pragmatic threshold of IOD ≥ 6%, couples were identified with approximately half the odds of achieving a live birth compared to those with IOD < 6% at similar female ages (OR = 0.51, 95% CI 0.28-0.94; P = 0.029). The adverse association between dsSDF and live birth was stronger at higher female ages. LIMITATIONS, REASONS FOR CAUTION: This study examined couples undergoing their first or only IVF cycle and did not include couples with repeat IVF failures. Limitations include potential centre-level confounding, which may benefit from mixed-effects modelling. We did not collect or adjust for several cycle-level covariates that influence live birth (e.g. IVF vs ICSI, number of oocytes retrieved, embryo transfer strategy, use of preimplantation genetic testing for aneuploidy, stimulation protocol), so residual confounding is possible. WIDER IMPLICATIONS OF THE FINDINGS: These results support dsSDF as a clinically relevant biomarker that complements conventional semen parameters. STUDY FUNDING/COMPETING INTEREST(S): The study was part-funded using an unrestricted medical educational grant provided by Merck Serono Limited (0111897641) to the Liverpool Women's Hospital. T.C.B.M., S.H.M., and E.B. were funded in part by UKRI SIP FMI and Peace Plus HF-TIC grants with Ulster University. L.R., A.S., M.L., C.J.L., L.P., and T.C.B.M. are employed at Examen Lab LTD. A.J.D. is a recipient of Merck Serono Limited (0111897641) grant to the Liverpool Women's Hospital. P.H. has received unrestricted research grants from Merck and Gedeon Richter Nordics and honoraria for lectures from Merck, Gedeon Richter, and IBSA. The remaining authors have nothing to disclose. TRIAL REGISTRATION NUMBER: N/A.

来源:Hum Reprod,查看原文。版权归原作者所有。

引用

  1. Humaidan P, Povlsen BB, Drakeley AJ, et al. Double-stranded sperm DNA fragmentation measured with neutral comet assay as a predictor of IVF outcomes: evidence from three European clinics in a multi-centred prospective study. Hum Reprod. 2026. PMID: 41903517. doi:10.1093/humrep/deag046

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。